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Besides fatigue, many Q fever fatigue syndrome (QFS) patients also complain of fre-
quently recurring upper respiratory tract infections with severe symptoms. We inves-
tigated whether immunologic dysregulation contributes to these complaints. Cytokine
and chemokine production was measured after stimulating monocytes of QFS patients
and age- and sex-matched healthy controls with LPS and several viral ligands. The
H3K4me3 mark of open chromatin was measured at the promoter regions of cytokines
and chemokines that differed significantly from healthy controls. Monocytes of QFS
patients produced significantly less TNF-α (p = 0.032), IL-1β (0.004, 0.024, and 0.008),
IL-6 (0.043), RANTES (0.033), IP-10 (0.049), MCP-1 (0.022), IL- 13 (0.029), and IL-10 (0.026)
than healthy controls when stimulated with various ligands. H3K4me3 expression was
significantly lower in QFS patients than in healthy controls on the promoter regions of
IL-1β (p = 0.004), MCP-1 (<0.001 and <0.001), IP-10 (<0.001), IL-10 (0.041), and IL-13
(<0.001, <0.001, and 0.001). QFS patients showed diminished cytokine responses to vari-
ous stimuli compared to age- and sex-matched healthy controls, likely due to epigenetic
remodeling and long-term memory as a result from the acute Q fever infection. This
might explain the upper respiratory tract ailments in QFS.
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Introduction
Q fever is a zoonosis caused by the intracellular Gram-negative
bacterium Coxiella burnetii [1]. Initial infection with C. burnetii
remains asymptomatic in around 60% of cases, but can also
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Figure 1. Production of TNF-α, IL-1β, and IL-6 in QFS patients compared to healthy controls, Monocytes were stimulated with RPMI, LPS, Poly I:C,
R848, or 5’ppp-dsRNA for 24 h. (A) Monocytes of QFS patients, stimulated with 5’ppp-dsRNA, produced significantly less TNF-α (p = 0.032) than
those of healthy controls. (B) Monocytes of QFS patients, stimulated with LPS, R848, and 5’ppp-dsRNA, produced significantly less IL-1β (p = 0.008,
p = 0.004, and p = 0.024, respectively) than those of healthy controls. (C) Monocytes of QFS patients, stimulated with LPS, Poly I:C, R848, and
5’ppp-dsRNA, show no significant difference in IL-6 production compared to those of healthy controls. Cytokines were measured with ELISA. Data
were analyzed with the Mann-Whitney test and are depicted as mean ± SEM. Data are derived from one single experiment that consisted of 15
patients and 11 healthy controls. Abbreviations: QFS, Q fever fatigue syndrome; RPMI, Roswell Park Memorial Institute culture medium; PolyI:C,
R848, and 5’ppp-dsRNA, various viral ligands. *p  0.05; **p  0.01
manifest as symptomatic disease, acute Q fever, usually man-
ifesting as a flu-like illness that is sometimes accompanied by
hepatitis or pneumonia [1, 2]. The Netherlands experienced the
largest Q fever outbreak ever reported between 2007 and 2011.
It is estimated that at least 32 200 individuals were infected,
and around 4000 patients notified having a symptomatic acute
Q fever infection [3]. During an acute Q fever infection, the C.
burnetii bacterium resides inside the phagolysosomes of mono-
cytes and macrophages [1, 2]. In order to survive and replicate
in the phagolysosome, or Coxiella containing vacuole, of these
cells, C. burnetii is known to alter and subvert various host cell
processes [4, 5].
Q fever fatigue syndrome (QFS) is a debilitating post-infective
fatigue syndrome developing in approximately 20% of patients
with an acute Q fever infection [6]. It is characterized by com-
plaints of fatigue that last for at least 6 months, often coin-
ciding with complaints of musculoskeletal pain, neurocognitive
problems, sleeping problems, headache, (night) sweating, and
mood disorders [7]. Many patients with QFS also complain of
frequently recurring and severe upper respiratory tracts infec-
tions. Although the exact etiology of QFS remains unclear,
results from previous studies and the nature of concomitant com-
plaints are compatible with an inflammatory component in its
pathophysiology [8, 9].
Recently, the dogma that innate immune cells, e.g. monocytes
and macrophages, are unable to acquire immunologic memory,
was challenged [10]. It was shown that monocytes and likely also
myeloid progenitor cells are able to acquire long-lasting immuno-
logic memory (also termed “trained immunity”) through epige-
netic remodeling at the promoter regions of various cytokines
[11, 12]. Depending on their initial challenge, these cells show
altered (decreased or increased) responses to secondary chal-
lenges such as infections [13, 14]. Given these findings, it could
be hypothesized that QFS patients who experience more frequent
and severe upper respiratory tract infections since their acute Q
fever infection, exhibit epigenetic remodeling of chromatin at the
level of immune genes involved in host defense against viral upper
respiratory tract infections. This remodeling could then result in
altered cytokine responses to such infections. We test this hypoth-
esis by conducting in vitro stimulation experiments on mono-
cyte responsiveness of QFS patients with frequently recurring and
severe upper respiratory tracts infections, together with an investi-
gation of epigenetic changes at various cytokine promoter regions
of these monocytes.
Results
Patients and controls
QFS patients had a median age of 47 (interquartile range, IQR,
41–54) and predominantly female distribution (66.67%). All QFS
patients had IgG phase I or phase II titres  1:16, but IgG phase I
 1:512, and none of them showed serological signs of an acute
or recent Q fever infection, reflected by IgM antibodies in absence
of IgG antibodies. All healthy controls had negative IgM phase I
and II, and IgG phase I and II titres.
Lower cytokine responses of QFS patients compared
to healthy controls
Monocytes of QFS patients produced significantly less TNF-αwhen
stimulated with 5’ppp-dsRNA (p = 0.032) than those of healthy
controls (Fig. 1A). This was also the case for IL-1βwhen stimulated
with R848 (p = 0.004), 5’ppp-dsRNA (p = 0.024), and LPS (p =
0.008; Fig. 1B). No significant differences were found for IL-6
(Fig. 1C).
By measuring expression of TNFα and IL-1β mRNA, we inves-
tigated whether the changes in cytokine levels were regulated
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Figure 2. mRNA expression of IL-β and TNF-α in QFS patients compared to healthy controls, Monocytes were stimulated with LPS, Poly
I:C, R848, or 5’ppp-dsRNA for 24 hours. (A) Monocytes of QFS patients showed significantly decreased mRNA expression of IL-1β com-
pared to healthy controls when stimulated with 5’ppp-dsRNA (p = 0.036). (B) Monocytes of QFS patients show no significantly difference
in mRNA expression of TNF-α compared to healthy controls. mRNA expression was measured with qPCR. The following primers were used:
TNFα FWD-5’-AACGGAGCTGAACAATAGGC-3’, REV-5’-TCTCGCCACTGAATAGTAGGG-3’, IL-1β FWD-5’-GCCCTAAACAGATGAAGTGCTC-3’, REV-5’-
GAACCAGCATCTTCCTCAG-3’. RNA expression was corrected for differences in loading concentration using the signal of housekeeping protein
GAPDH. Data were analyzed with the Mann–Whitney test and are depicted as mean ± SEM. Data are derived from one single experiment that
consisted of 13 patients and seven healthy controls. Abbreviations: QFS, Q fever fatigue syndrome; Poly I:C, R848, and 5’ppp-dsRNA, various viral
ligands; RPMI, Roswell Park Memorial Institute culture medium; qPCR, quantitative real-time PCR. *p  0.05; **p  0.01
pretranscriptionally, transcriptionally, or posttranscriptionally. A
similar trend for IL-1β and TNF-α was observed in qPCR data
(Fig. 2A and B), showing significantly decreased IL-1β mRNA
expression in monocytes of QFS patients compared to those of
healthy controls, when stimulated with 5’ppp-dsRNA (p = 0.036).
After this initial observation, a Luminex assay was performed
for broader exploration of involved cytokines and chemokines. A
significantly decreased production of IL-6 (p = 0.043), RANTES
(p= 0.033), and IP-10 (p= 0.049)was found bymonocytes of QFS
patients compared to those of healthy controls when stimulated
with 5’ppp-dsRNA, together with a near significantly decreased
production of IL-10 (p = 0.056; Fig. 3B and D–F). This was also
the case for MCP-1 (p = 0.022) when stimulated with R848, and
IL-10 (p = 0.026) when stimulated with LPS (Fig. 3C and F).
Monocytes of QFS patients produced more IL-13 (p = 0.029) than
those of healthy controls when stimulated with R848 (Fig. 3G).
Contrary to ELISA, no significant differences in IL-1β production
were found with the Luminex assay (Fig. 3A).
Histone modifications at cytokine promoter regions
of QFS patients compared to healthy controls
We investigated whether epigenetic markers on cytokine promoter
regions were different between patients and controls. Histone
modifications at cytokine promoter regions have been associated
with trained immunity [11], especially histone 3 lysine 4 trimethy-
lation (H3K4me3). At the promoter regions of IL-1β, MCP-1, IP-10,
IL-10, and IL-13, a decreased expression of H3K4me3was found in
QFS patients compared to healthy controls, for; IL-1β (p = 0.004,
primer 5), MCP-1 (p < 0.001, primer 1 and p < 0.001, primer
2), IP-10 (p < 0.001, primer 1), IL-10 (p = 0.041, primer 2), and
IL-13 (p < 0.001, primer 1, p < 0.001, primer 2, and p = 0.001,
primer 3; Fig. 4A–E). Negative and positive controls for H3K4me3
are depicted in Supporting Information Fig. 1.
Discussion
In this study, we discovered that monocytes of QFS patients
who experience more frequent and severe upper respiratory
tract infections since their acute Q fever infection, had in gen-
eral a decreased cytokine response to viral ligands and LPS.
This decreased response was most likely regulated on a (pre-
)transcriptional level given the linked mRNA expression data for
IL-1β and, to a lesser extent, TNF-α. In addition we demonstrated
that there was a decreased expression of the open chromatin mark
H3K4me3 on the promoter regions of these cytokines. It is con-
ceivable that these low responses lead to greater susceptibility to
viral infection in the upper airways.
The most common pathogens to induce upper respiratory
tract infections are Rhinoviruses, Coronaviruses, and Influenza
viruses [15]. Most research on the role of antiviral cytokine and
chemokine responses was done on Influenza. When looking at dis-
ease severity, human studies show consensus and indicate toward
an association with increased cytokine and chemokine responses
[16, 17]. Studies on disease susceptibility are however scarce,
mainly consist of mouse models, and show conflicting results.
Both positive and negative associations are found when looking
at disease severity, morbidity, and mortality in mice deficient for
IL-6 [18] and IL-1 [19, 20], MCP-1 [21], and IP-10 [21] recep-
tors. Nonetheless, it is conceivable that the decreased cytokine
responses in our cohort of QFS patients contribute to an increased
susceptibility to viral upper respiratory tract infections. Previous
C© 2019 The Authors. European Journal of Immunology published by
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Figure 3. Production of IL-1β, IL-6, MCP-1, RANTES, IP-10, IL-10, and IL-13 in QFS patients compared to healthy controls, Monocytes were exposed
to RPMI, LPS, Poly I:C, R848, or 5’ppp-dsRNA for 24 h. (A) Monocytes of QFS patients, stimulated with LPS, Poly I:C, R848, and 5’ppp-dsRNA,
showed no significant difference in IL-1β production compared to those of healthy controls. (B) Monocytes of QFS patients, stimulated with 5’ppp-
dsRNA, produced significantly less IL-6 (p = 0.043) than those of healthy controls. (C) Monocytes of QFS patients, stimulated with R848, produced
significantly less MCP-1 (p = 0.022) than those of healthy controls. (D) Monocytes of QFS patients, stimulated with 5’ppp-dsRNA, produced
significantly less RANTES (p = 0.033) than those of healthy controls. (E) Monocytes of QFS patients, stimulated with 5’ppp-dsRNA, produced
significantly less IP-10 (p = 0.049) than those of healthy controls. (F) Monocytes of QFS patients, stimulated with LPS, produced significantly less
IL-10 (p = 0.026) than those of healthy controls. (G) Monocytes of QFS patients, stimulated with R848, produced significantly more IL-13 (p = 0.029)
than those of healthy controls. Cytokines and chemokines were measured with luminex assay. Data were analyzed with the Mann–Whitney test
and are depicted asmean ± SEM. Data are derived from one single experiment that consisted of 15 patients and 11 healthy controls. Abbreviations:
MCP, monocyte chemoattractant protein; RANTES, regulated on activation, normal T cell expressed and secreted; RPMI, Roswell Park Memorial
Institute culture medium; IP, interferon gamma-induced protein; QFS, Q fever fatigue syndrome; Poly I:C, R848, and 5’ppp-dsRNA, various viral
ligands. *p  0.05
studies on cytokine responses in QFS found that white blood cells
of QFS patients produce higher amounts of IL-6 and IFN-γ when
exposed to Coxiella antigen [8, 9]. One could therefore argue that
immune regulation in QFS is ligand dependent, which makes it
challenging to decipher its exact underlying immunopathologic
mechanisms. It should be noted that this study solely included
QFS patients who experience more frequent and severe upper res-
piratory tract infections since their acute Q fever while the above
mentioned studies made no such distinction.
The finding that stimulation of primary monocytes from QFS
patients results in altered inflammatory responses in the long term,
supports the concept that an acute Q fever infection might be able
to induce long-term changes in monocytes, and therefore possibly
also myeloid progenitor cells and macrophages. The concept of
trained immunity is based on metabolic and epigenetic remod-
eling of monocytes, macrophages, and their progenitor cells,
following insults such as infection, vaccination, or inflammatory
diseases (e.g. atherosclerosis) [10–14]. Epigenetic remodeling
on promoter regions of pro-inflammatory cytokines, e.g. TNF-α
and IL-6, can result in transcriptionally active chromatin, often
accompanied by higher expression of open chromatin marks such
as H3K4me3 [11, 22]. Such remodeling can result in an increased
inflammatory response upon a second, nonspecific, infectious
stimulus. As a counterbalance of trained immunity, certain incen-
tives are known to inflict long lasting decreased inflammatory
responses, i.e. tolerance [22–25]. Such a process, inflicted by a
strong initial incentive, e.g. acute Q fever infection, could perhaps
explain the altered cytokine responses in these QFS patients and
arises from similar metabolic and epigenetic remodeling.
We found that monocytes of QFS patients produced less
cytokines than those of age- and sex-matched healthy controls
upon stimulation with various ligands. It could therefore be pos-
tulated that, in these patients, the acute Coxiella infection resulted
in altered monocyte responsiveness through long-lasting epige-
netic, and metabolic, remodeling at the time of infection. Given
the differing results in monocyte responsiveness when using var-
ious ligands, such remodeling is likely to be complex and vary
per cytokine and chemokine promoter region. If monocytes of
QFS patients are indeed transcriptionally altered upon encoun-
tering infections, e.g. upper respiratory tract viruses, it could be
conceived that this leads to greater susceptibility to viral upper
respiratory tract infections.
Since mRNA expression of IL-1β and TNF-α show a similar
trend as cytokine production when comparing QFS patients to
C© 2019 The Authors. European Journal of Immunology published by
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Figure 4. Expression of H3K4me3 inmonocytes of QFS patients compared to healthy controls, Expression of H3K4me3 inmonocytes of QFS patients
was compared to healthy controls, using various primers. (A) Decreased expression of H3K4me3 on the IL-1β promoter region, using primer 5 (p =
0.004). (B) Decreased expression of H3K4me3 on MCP-1 promoter region, using primer 1 and 2 (p < 0.001 and p < 0.001, respectively). (C) Decreased
expression of H3K4me3 on the IP-10 promoter region, using primer 1 (p < 0.001). (D) Decreased expression of H3K4me3 on the IL-10 promoter
region, using primer 2 (p = 0.041), not primer 1 (p = 0.078). (E) Decreased expression of H3K4me3 on the IL-13 promoter region, using primer 1, 2,
and 3 (p < 0.001, p < 0.001, and p = 0.001, respectively). H3K4me3 expression was measured with qPCR. Primers used in the reaction are listed
in Table S1. Samples were analyzed following a comparative Ct method, myoglobin was used as a negative control and H2B as a positive control
for H3K4me3. Data were analyzed with the Mann–Whitney test and are depicted as mean ± SEM. Data are derived from one single experiment
that consisted of 15 patients and 16 healthy controls. Abbreviations: H3K4me3, histone 3 lysine 4 trimethylation; MCP, monocyte chemoattractant
protein; IP, interferon gamma-induced protein; QFS, Q fever fatigue syndrome; qPCR, quantitative real-time PCR. *p  0.05; **p  0.01; ***p  0.001
healthy controls, it is suggestive that the origin of the differences
seen between these groups is regulated (pre-)transcriptionally,
e.g. through epigenetic remodeling.
Investigation of H3K4me3 on the promoter regions of IL-1β,
MCP-1, IP-10, IL-10, and IL-13 showed a decreased expression,
suggestive for less transcriptionally active chromatin. This could
in part explain the decreased mRNA expression and cytokine pro-
duction in these QFS patients compared to their age- and sex-
matched healthy controls. However, it should be noted that this
is an investigation of a very specific part and alteration on these
promoter regions. Many more modifications are known to occur at
these regions, which could all influence activation, inhibition, but
also each other [23, 26]. Perhaps these results could best serve as
an indication that the immunologic alterations seen in QFS could
in part be explained by epigenetic remodeling in myeloid cells.
This epigenetic remodeling could very well be induced by acute
infection with C. burnetii, and result in long-lasting changes in
monocytes, macrophages, and their progenitor cells. Future inves-
tigations on Coxiella-induced epigenetic remodeling in these cells
are of great interest but should employ a broader scope, for exam-
ple by means of ChIP-sequencing.
As the results of this study merely serve as an indication that
epigenetic remodelingmight contribute to the diminished immune
response in QFS patients who report having more frequent and
severe upper respiratory tract infections since their acute Q fever
infection, a larger confirmatory study is warranted. We suggest
employing ChIP-sequencing and investigation of methylated DNA
in a prospective longitudinal study in which QFS patients with
more frequent and severe upper respiratory tract infections are
compared with: (1) QFS patients without such complaints, (2)
patients who recovered from the acute Q fever infection without
persistent complaints, and (3) healthy controls, all matched for
age and sex. In order to avoid recall bias, it would be of interest
to objectify the amount and severity of upper respiratory tract
infections in these patients.
Conclusion
In conclusion, QFS patients who report having more frequent and
severe upper respiratory tract infections since their acute Q fever
infection showed diminished immune responses to various stimuli
C© 2019 The Authors. European Journal of Immunology published by
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compared to age- and sex-matched healthy controls, possibly due
to epigenetic remodeling as a result from the acute Q fever infec-
tion. Future research on the role of Coxiella-induced epigenetic
changes in the innate immune cells of these patients and their
role in the complaints they exhibit is warranted.
Materials and Methods
Study population
The study population consisted of 15 QFS patients who reported
having more (3/year), more severe, and longer-lasting upper
respiratory tract infections since their acute Q fever infection.
Upper respiratory tract infections were not documented. QFS
patients were matched for age- and sex (±10 years) with 16
healthy controls.
All QFS patients protracted QFS during the Dutch Q fever out-
break between 2007 and 2011 and were diagnosed at the Rad-
boud Expert Center for Q fever, Nijmegen, the Netherlands, after
a uniform work-up according to the Dutch guideline on QFS [27].
All QFS patients met the following diagnostic criteria: (i) fatigue
lasted  6 months; (ii) sudden onset of severe fatigue (defined
as a score  35 on the subscale fatigue severity of the Check-
list Individual Strength questionnaire), or significant increase in
fatigue, both related to a symptomatic acute Q fever infection; (iii)
chronic Q fever and other causes of fatigue, somatic or psychiatric,
were excluded; and (iv) fatigue resulted in significant functional
impairment (defined as a total score 450 on the Sickness Impact
Profile-8 questionnaire).
All healthy controls, i.e., colleagues from the department of
Internal Medicine at the Radboud University Medical Center,
Nijmegen, who lived in areas previously endemic for Q fever
during the Dutch outbreak between 2007 and 2011, tested
negative on Q fever serology (Immunofluorescence assay, or IFA;
Focus Diagnostics, Cypress, CA, USA), and had a score <35 on
the subscale fatigue severity of the Checklist Individual Strength
questionnaire and a score <450 on the Sickness Impact Profile-8
questionnaire.
Monocyte isolation and stimulation
PBMC isolation was performed by dilution of blood in PBS (1:1)
and fractions were separated by density centrifugation over Ficoll-
Paque (Ficoll-Paque Plus; GE healthcare, Zeist, The Netherlands).
Cells were washed three times with cold PBS and resuspended
in RPMI 1640 Dutch modification culture medium (Life Tech-
nologies/ Invitrogen, Breda, the Netherlands) supplemented with
50 μg/mL gentamicin, 2 mM Glutamax, and 1 mM pyruvate (Life
Technologies). Percoll isolation of monocytes was performed as
previously described [28]. Briefly, 150–200 × 106 PBMCs were
layered on top of a hyperosmotic Percoll solution (48.5% Percoll,
41.5% sterile H2O, 0.16 M filter sterilized NaCl) and centrifuged
for 15 min at 580 × g. The interphase layer was isolated and cells
were washed once with cold PBS. Cells were resuspended in cul-
ture medium as described above. A total of 1 × 105 monocytes
were seeded per well on flat-bottom 96-well plates (Corning, New
York, USA) and stimulated for 24 h with RPMI only as a neg-
ative control, LPS (Sigma–Aldrich, St. Louis, MO; from E. coli),
or various viral ligands. After 24 h, plates were centrifuged and
supernatants were stored at −20°C until cytokine assessment.
Viral ligands
The following viral ligands were used in the experiments:
10 μg/ml Poly I:C (polyinosinic:polycytidylic acid; Invivogen,
Toulouse, France), signaling through TLR-3, 10 μg/mL R848
(Resiquimod; Invivogen, Toulouse, France) signaling through
TLR7 and TLR8), and 1μg/mL 5’ppp ds-RNA (a ligand for the cyto-
plasmic retinoic acid-inducible protein (RIG) receptor that senses
viral RNA (Invivogen, Toulouse, France).
Quantitative PCR
RNA was isolated using TRIzol reagent (Invitrogen) according to
the protocol supplied by the manufacturer, and RNA was con-
verted into cDNA using iScript cDNA synthesis kit (Biorad, Her-
cules, CA). Quantitative real-time PCR (qPCR) was performed
using power SYBR Green PCR master mix (Applied Biosystems,
Carlsbad, CA) and the following primers: TNF-α FWD-5’-AACGG-
AGCTGAACAATAGGC-3’, REV-5’-TCTCGCCACTGAATAGTAGGG-
3’, IL-1β FWD-5’-GCCCTAAACAGATGAAGTGCTC-3’, REV-5’-
GAACCAGCATCTTCCTCAG-3’. PCR was performed using an
Applied Biosystem StepOne PCR system using PCR conditions
2min 50°C, 10min 95°C, followed by 40 cycles at 95°C for 15 s,
and 60°C for 1min. RNA expression was corrected for differences
in loading concentration using the signal of housekeeping protein
GAPDH.
Chromatin immunoprecipitation
For the assessment of histone methylation, ChIP was performed as
described previously [29]. In short, monocytes were cross-linked
in methanol free 1% formaldehyde (28908, Thermo Scientific),
followed by sonication to shear-DNA and IP using antibodies
against H3K4me3 (Diagenode, Seraing, Belgium). ChIPed DNA
was processed further for qPCR analysis. Primers used in the reac-
tion are listed in Table S1. Samples were analyzed following a
comparative Ct method, myoglobin was used as a negative con-
trol and H2B as a positive control for H3K4me3, according to the
manufacturer’s instructions.
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Determination of altered cytokine responses of QFS
patients compared to healthy controls
By determining production of monocyte-derived cytokines IL-6,
TNF-α, and IL-1β in monocytes of QFS patients compared to
healthy controls upon stimulation with LPS and various viral lig-
ands, we investigated whether a difference in monocyte reactivity
could be observed between QFS patients with frequently recur-
ring and severe upper respiratory tracts infections, and healthy
controls.
Cytokine and chemokine assays
Cytokine and chemokine production were determined in super-
natants using commercial ELISA kits for IL-1 β, TNF-α (R&D
systems, MN, USA), and IL-6 (Sanquin, Amsterdam, the Nether-
lands), and by using Luminex technology (Thermo Fisher Scien-
tific, Waltham, USA; Cytokine 25-plex Human Panel), following
the manufacturer’s instructions. Cytokines and chemokines deter-
mined by Luminex assay are listed in Table S2.
Histone modifications at cytokine promoter regions
of QFS patients compared to healthy controls
We investigated whether epigenetic markers on cytokine promoter
regions were different between patients and controls. Histone
modifications at cytokine promoter regions have been associated
with trained immunity [11], especially H3K4me3.
Statistical analysis
Data were analyzed using Graphpad Prism (Graphpad Software
Inc., version 5.03). The Mann–Whitney test was used to determine
differences between groups. Statistical significance was attained
if p < 0.05.
Ethical statement
All participants provided written informed consent, and the study
was approved by the Medical Ethical Review Committee of the
Arnhem-Nijmegen region.
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